Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schelotto

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1992
Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine releaseS Carozzi, M G Nasini, P M Caviglia, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1994
Peritoneal dialysis solution pH and Ca2+ concentration regulate peritoneal macrophage and mesothelial cell activationS Carozzi, P M Caviglia, M G Nasini, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
A biocompatibility study on peritoneal dialysis solution bags for CAPDS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1989
Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitisS Carozzi, M G Nasini, C Schelotto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1990
Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1990
Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patientsS Carozzi, G Nasini, C Schelotto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patientsS Carozzi, A Ramello, M G Nasini, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1992
Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine releaseS Carozzi, M G Nasini, P M Caviglia, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1994
Peritoneal dialysis solution pH and Ca2+ concentration regulate peritoneal macrophage and mesothelial cell activationS Carozzi, P M Caviglia, M G Nasini, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
A biocompatibility study on peritoneal dialysis solution bags for CAPDS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1989
Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitisS Carozzi, M G Nasini, C Schelotto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1990
Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1990
Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patientsS Carozzi, G Nasini, C Schelotto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patientsS Carozzi, A Ramello, M G Nasini, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
Pageof 2